Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Pediatric Studies Characteristics - Detail
  • Print
  • Share
  • E-mail
-
 
Approval Date:  12/15/2010
 
Trade Name:  Uroxatral
 
Generic or Proper Name (*):  alfuzosin
 
Indications Studied:  Elevated detrusor leak point pressure of neurologic origin
 
Therapeutic Category:  Urology
 
Ages Studied:  2-16 years
 
Study #:  3
 
Study Type:  Efficacy/Safety
 
Study Design:  Open Label
 
No Patients:  25
 
No Centers:  13
 
No Countries:  8
 
BPCA(B), PREA(P):  B
 
Asian:  0
 
Black:  0
 
Other:  7
 
White:  18
 
Native Hawaiian or Pacific Islander:  0
 
American Indian/Alaska Native:  0
 
Hispanic/Latino:  0
 
Non-Hispanic/Non Latino:  0
 
Countries:  (India, Maylasia, Poland, Russia, Singapore, Slovakia, Taiwan, and Turkey
 
-
-